title: Gamma delta TCR+, type-2 cytokine produced by hybridoma cells produced in mice given portal vein pretransplant immunization and allogeneic grafts can increase graft survival on adoptive transfer.
authors.affiliation: Toronto Hospital, Transplantation Research Division, Canada.
authors.forename: R
authors.initials: R
authors.lastname: Gorczynski
authors.forename: Z
authors.initials: Z
authors.lastname: Chen
authors.forename: G
authors.initials: G
authors.lastname: Levy
mesh_terms: D019264:Adoptive Transfer; D000818:Animals; D016207:Cytokines / Q000096:biosynthesis*; D006085:Graft Survival / Q000276:immunology*; D006825:Hybridomas / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D011169:Portal Vein; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000096:biosynthesis / Q000276:immunology; D016692:Receptors, Antigen, T-Cell, gamma-delta / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology*; D016038:Skin Transplantation / Q000276:immunology*
chemical_list: D016207:Cytokines; D016693:Receptors, Antigen, T-Cell, alpha-beta; D016692:Receptors, Antigen, T-Cell, gamma-delta